Hillstream BioPharma

HILLSTREAM BIOPHARMA (NASDAQ:HILS)

14/02/2022 15:04

Hillstream BioPharma Provides Business Review with Key Pipeline Updates

Voir tous les communiqués de Hillstream BioPharma

HILLSTREAM BIOPHARMA (NASDAQ:HILS)

11/02/2022 13:15

SAVE THE DATES: Hillstream BioPharma Announces R&D Day on February 24, 2022 and Business Review on Monday February 14, 2022

Voir tous les communiqués de Hillstream BioPharma

HILLSTREAM BIOPHARMA (NASDAQ:HILS)

01/02/2022 15:40

Hillstream BioPharma Announces Acceptance of Abstract at AACR 2022 Annual Meeting Highlighting HSB-510, a Novel Quatramer-based, First-in-Class Dual Inhibitor of HDAC6 and PI3K-delta Downregulating c-myc Expression

Voir tous les communiqués de Hillstream BioPharma

HILLSTREAM BIOPHARMA (NASDAQ:HILS)

26/01/2022 14:30

Hillstream BioPharma and University of Massachusetts Chan Medical School Announce Research Collaboration using CRISPR and Computational Approaches to Advance The Hillstream Ferroptomic Atlas

Voir tous les communiqués de Hillstream BioPharma

HILLSTREAM BIOPHARMA (NASDAQ:HILS)

14/01/2022 22:00

Hillstream BioPharma Announces Closing of Initial Public Offering

Voir tous les communiqués de Hillstream BioPharma

HILLSTREAM BIOPHARMA (NASDAQ:HILS)

12/01/2022 01:55

Hillstream BioPharma Announces Pricing of Initial Public Offering

Voir tous les communiqués de Hillstream BioPharma

1